Damora Therapeutics, Inc.
Pharmaceutical company · Waltham, Massachusetts, United States · Nasdaq: DMRA
Damora Therapeutics, Inc. is a pharmaceutical company headquartered in Waltham, Massachusetts, United States. Its earliest recorded incorporation is in 2019. Its shares trade on Nasdaq under the ticker DMRA. It has reported private securities offerings to the US SEC, most recently $285 million sold in a notice filed in 2025.
Damora Therapeutics at a glance
What does Damora Therapeutics do?
Private fundraising reported to the SEC
3 Form D notices; the most recent reported $285 million sold (2025).
Frequently asked questions about Damora Therapeutics
Where is Damora Therapeutics headquartered?
Damora Therapeutics, Inc. is headquartered in Waltham, Massachusetts, United States.
What does Damora Therapeutics do?
Damora Therapeutics, Inc. is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.
Is Damora Therapeutics a public company?
Yes. Damora Therapeutics, Inc. trades on Nasdaq under the ticker DMRA.
When was Damora Therapeutics founded?
The earliest incorporation on record for Damora Therapeutics, Inc. is in 2019, according to public company registers.
Similar companies
- Mustang Bio, Inc.Waltham, Massachusetts, United States
- Alkermes IncWaltham, Massachusetts, United States
- Spyre Therapeutics, Inc.Waltham, Massachusetts, United States
- Cogent Biosciences, Inc.Waltham, Massachusetts, United States
- Viridian Therapeutics, Inc.\DEWaltham, Massachusetts, United States
- Dyne Therapeutics, Inc.Waltham, Massachusetts, United States
- Korsana Biosciences, Inc.Waltham, Massachusetts, United States
- Jade Biosciences, Inc.Waltham, Massachusetts, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-25. Data licences